` MOVE (Medacta Group SA) vs Swiss Market Index Comparison - Alpha Spread

MOVE
vs
Swiss Market Index

Over the past 12 months, MOVE has underperformed Swiss Market Index, delivering a return of -3% compared to the Swiss Market Index's 1% growth.

Stocks Performance
MOVE vs Swiss Market Index

Loading
MOVE
Swiss Market Index
Add Stock

Performance Gap
MOVE vs Swiss Market Index

Loading
MOVE
Swiss Market Index
Difference

Performance By Year
MOVE vs Swiss Market Index

Loading
MOVE
Swiss Market Index
Add Stock

Competitors Performance
Medacta Group SA vs Peers

Swiss Market Index
MOVE
ABT
ISRG
BSX
SYK
Add Stock

Medacta Group SA
Glance View

Market Cap
2.3B CHF
Industry
Health Care

Medacta Group SA, hailing from the picturesque setting of Castel San Pietro, Switzerland, stands as a prominent player in the global medical technology arena. Founded in 1999, the company has capitalized on a family-driven passion for innovation and precision in the orthopedic industry. Guided by its roots, Medacta designs and supplies orthopedic implants and surgical instruments, with a staunch focus on products for joint replacement, spine surgery, and sports medicine. But beyond mere manufacturing, Medacta combines cutting-edge research with in-depth medical training programs, ensuring that healthcare professionals are not only equipped with superior products but also with the necessary skills to optimize patient outcomes. The company’s MyPractice Development Plan exemplifies this by pairing technical support with educational efforts, fostering both confidence and competence among its professional clients. Medacta’s business model is a synthesis of product sales and continuous practitioner engagement. Revenue streams primarily flow from the direct sale of their extensive product portfolio, including implants and surgical instruments, to hospitals and surgical centers. However, Medacta's strategy extends its competitive advantage by nurturing strong relationships with medical professionals through training and support initiatives. This symbiotic approach ensures a feedback loop that not only tailors their offerings to the evolving needs of the marketplace but also solidifies client loyalty. Their innovative and educational initiatives secure a unique position in the market, allowing Medacta to maintain a balance of economic success and industry leadership by focusing on quality, innovation, and education.

MOVE Intrinsic Value
113.2 CHF
Overvaluation 1%
Intrinsic Value
Price
Back to Top